Emerging research offers promising new directions for neurological disease management. A Stanford Medicine study shows that epilepsy drugs targeting hyperactivity in the reticular thalamic nucleus can reverse autism-related symptoms in mice, highlighting shared neural underpinnings. Additionally, non-invasive neuromodulation via the Uris device demonstrated efficacy in Parkinson’s symptom relief. These advances pave the way for innovative treatment paradigms in complex neurodevelopmental and neurodegenerative conditions.